Global Health balance sheet

As of Mar 2026
Total assets
₹5,905cr+23.9% on Mar 2025
Shareholders' equity
₹3,984cr+17.6% on Mar 2025
Total debt
₹1,190cr+262.9% on Mar 2025
Cash and investments
₹127cr−44.7% on Mar 2025
₹ crore except per share
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Non-current assets
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
3,7791,9751,8131,708
132529386327
16.06.54.35.2
0.24.81.30.0
2.62.70.10.1
11230.027.242.9
11432.827.243.0
15.633.061.325.7
173652502428
4,2303,2332,7952,536
Current assets
79.067.166.960.4
411292215194
127230425767
1,003892751511
32.232.834.432.7
1,5741,4471,4251,505
—19.016.914.1
1,6751,5331,5091,579
5,9054,7664,3044,116
Equity
53.753.753.753.6
3,9083,3332,8522,375
3,9623,3862,9062,428
22.71.1−0.0453
3,9843,3882,9062,428
Liabilities
1,127264283737
0.3408386258
1,127672670996
11466.257.754.0
0.00.024.218.8
52.322.129.046.8
1,2947607811,115
63.063.8136105
242195187195
133162166149
439420489448
30.047.436.525.8
15915192.398.4
627619618573
1,9211,3791,3981,688
5,9054,7664,3044,116
Assets — additional as-filed lines
22.40.00.0—
Trade payables — MSME split
87.979.4——
154115——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MEDANTA₹1,299.70

Global Health Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHAPOLLOHOSPFORTISGLAXOANTHEMAJANTPHARMIPCALABABBOTINDIAMcap ₹34,922 Cr
View
In ₹ Crore except Per Share
As of
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment1,707.81,812.91,975.33,778.73,778.7
+ Capital Work-in-Progress327.0386.3528.5132.2132.2
+ Other Intangibles5.24.36.516.016.0
+ Intangibles under Development0.01.34.80.20.2
+ Non-current Investments0.10.12.72.62.6
+ Other Non-current Financial Assets42.927.230.0111.7111.7
Non-current Financial Assets43.027.232.8114.2114.2
+ Deferred Tax Assets25.761.333.015.615.6
+ Other Non-current Assets427.8502.0652.3173.1173.1
Total Non-current Assets2,536.52,795.33,233.14,230.14,230.1
Current Assets
+ Inventories60.466.967.179.079.0
+ Trade Receivables194.2215.3291.9411.2411.2
+ Cash & Cash Equivalents767.2424.6230.2127.3127.3
+ Other Bank Balances510.9750.7892.11,002.91,002.9
+ Other Current Financial Assets32.734.432.832.232.2
Current Financial Assets1,505.01,425.01,447.01,573.61,573.6
+ Other Current Assets14.116.919.0——
Total Current Assets1,579.51,508.71,533.11,674.91,674.9
Total Assets4,116.04,304.14,766.25,905.05,905.0
Equity
+ Equity Share Capital53.653.753.753.753.7
+ Other Equity / Reserves2,374.62,851.93,332.73,907.83,907.8
Equity — Owners of Parent2,428.22,905.63,386.43,961.63,961.6
+ Minority Interest452.8-0.01.122.722.7
Total Equity2,428.22,905.63,387.53,984.33,984.3
Liabilities
+ Borrowings — Non-current737.1283.5264.11,127.11,127.1
+ Other Non-current Financial Liab258.4386.4407.50.30.3
Non-current Financial Liabilities995.5669.9671.61,127.41,127.4
+ Provisions — Non-current54.057.766.2113.9113.9
+ Deferred Tax Liabilities18.824.20.00.00.0
+ Other Non-current Liabilities46.829.022.152.352.3
Non-current Liabilities1,115.2780.7759.91,293.61,293.6
+ Borrowings — Current105.1135.963.863.063.0
+ Trade Payables194.7186.8194.8242.4242.4
+ Other Current Financial Liab148.6166.3161.6133.2133.2
Current Financial Liabilities448.4489.0420.2438.6438.6
+ Provisions — Current25.836.547.430.030.0
+ Other Current Liabilities98.492.3151.2158.6158.6
Current Liabilities572.6617.7618.8627.1627.1
Total Liabilities1,687.81,398.51,378.71,920.71,920.7
Total Equity & Liabilities4,116.04,304.14,766.25,905.05,905.0
Assets — additional as-filed lines
+ Current Tax Assets—0.00.022.422.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current——79.487.987.9
+ Dues to Other Creditors — Current——115.4154.4154.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.